|
1
|
Aitzetmuller K: Santalbic acid in the
plant kingdom. Plant Syst Evol. 298:1609–1617. 2012. View Article : Google Scholar
|
|
2
|
Shawar RM, Humble DJ, Van Dalfsen JM,
Stover CK, Hickey MJ, Steele S, Mitscher LA and Baker W: Rapid
screening of natural products for antimycobacterial activity by
using luciferase-expressing strains of Mycobacterium bovis BCG and
Mycobacterium intracellulare. Antimicrob Agents Chemother.
41:570–574. 1997.PubMed/NCBI
|
|
3
|
Jones GP, Rao KS, Tucker DJ, Richardson B,
Barnes A and Rivett DE: Antimicrobial activity of santalbic acid
from the oil of Santalum-Acuminatum (Quandong). Int J Pharmacogn.
33:120–123. 1995. View Article : Google Scholar
|
|
4
|
Croft KD, Beilin LJ and Ford GL:
Differential inhibition of thromboxane B2 and leukotriene B4
biosynthesis by two naturally occurring acetylenic fatty acids.
Biochim Biophys Acta. 921:621–624. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Nugteren DH and Christ-Hazelhof E:
Naturally occurring conjugated octadecatrienoic acids are strong
inhibitors of prostaglandin biosynthesis. Prostaglandins.
33:403–417. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li G, Singh A, Liu Y, Sunderland B and Li
D: Comparative effects of sandalwood seed oil on fatty acid
profiles and inflammatory factors in rats. Lipids. 48:105–113.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Imig JD and Hammock BD: Soluble epoxide
hydrolase as a therapeutic target for cardiovascular diseases. Nat
Rev Drug Discov. 8:794–805. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang D and Dubois RN: Eicosanoids and
cancer. Nat Rev Cancer. 10:181–193. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Rothwell PM, Price JF, Fowkes FG,
Zanchetti A, Roncaglioni MC, Tognoni G, Lee R, Belch JF, Wilson M,
Mehta Z and Meade TW: Short-term effects of daily aspirin on cancer
incidence, mortality, and non-vascular death: Analysis of the time
course of risks and benefits in 51 randomised controlled trials.
Lancet. 379:1602–1612. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Dembitsky V: Anticancer activity of
natural and synthetic acetylenic lipids. Lipids. 41:883–924. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gupta RA, Tejada LV, Tong BJ, Das SK,
Morrow JD, Dey SK and DuBois RN: Cyclooxygenase-1 is overexpressed
and promotes angiogenic growth factor production in ovarian cancer.
Cancer Res. 63:906–911. 2003.PubMed/NCBI
|
|
12
|
Cho M, Kabir SM, Dong Y, Lee E, Rice VM,
Khabele D and Son DS: Aspirin blocks EGF-stimulated cell viability
in a COX-1 dependent manner in ovarian cancer cells. J Cancer.
4:671–678. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wu WK, Sung JJ, Wu YC, Li HT, Yu L, Li ZJ
and Cho CH: Inhibition of cyclooxygenase-1 lowers proliferation and
induces macroautophagy in colon cancer cells. Biochem Biophys Res
Commun. 382:79–84. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sano H, Noguchi T, Miyajima A, Hashimoto Y
and Miyachi H: Anti-angiogenic activity of basic-type, selective
cyclooxygenase (COX)-1 inhibitors. Bioorg Med Chem Lett.
16:3068–3072. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Carmeliet P and Jain RK: Angiogenesis in
cancer and other diseases. Nature. 407:249–257. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Schwartz GK and Shah MA: Targeting the
cell cycle: A new approach to cancer therapy. J Clin Oncol.
23:9408–9421. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liu YD, Longmore RB and Fox JED:
Separation and identification of ximenynic acid isomers in the seed
oil of Santalum spicatum RBr as their 4,4-dimethyloxazoline
derivatives. J Am Oil Chem Soc. 73:1729–1731. 1996. View Article : Google Scholar
|
|
18
|
Sun G, Zhou Y, Li H, Guo Y, Shan J, Xia M,
Li Y, Li S, Long D and Feng L: Over-expression of microRNA-494
up-regulates hypoxia-inducible factor-1 alpha expression via
PI3K/Akt pathway and protects against hypoxia-induced apoptosis. J
Biomed Sci. 20:1002013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Herrmann E, Call J, Hernandez-Lloreda MV,
Hare B and Tomasello M: Humans have evolved specialized skills of
social cognition: The cultural intelligence hypothesis. Science.
317:1360–1366. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Han Z, Hendrickson EA, Bremner TA and
Wyche JH: A sequential two-step mechanism for the production of the
mature p17:p12 form of caspase-3 in vitro. J Biol Chem.
272:13432–13436. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Vaziri H, Dessain SK, Ng Eaton E, Imai SI,
Frye RA, Pandita TK, Guarente L and Weinberg RA: hSIR2 (SIRT1)
functions as an NAD-dependent p53 deacetylase. Cell. 107:149–159.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ford J, Jiang M and Milner J:
Cancer-specific functions of SIRT1 enable human epithelial cancer
cell growth and survival. Cancer Res. 65:10457–10463. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kikuchi H, Takami Y and Nakayama T: GCN5:
A supervisor in all-inclusive control of vertebrate cell cycle
progression through transcription regulation of various cell
cycle-related genes. Gene. 347:83–97. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Williams CS, Mann M and DuBois RN: The
role of cyclooxygenases in inflammation, cancer, and development.
Oncogene. 18:7908–7916. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Regan JW: EP2 and EP4 prostanoid receptor
signaling. Life Sci. 74:143–153. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Neufeld G, Cohen T, Gengrinovitch S and
Poltorak Z: Vascular endothelial growth factor (VEGF) and its
receptors. Faseb J. 13:9–22. 1999.PubMed/NCBI
|
|
27
|
Salcedo R, Ponce ML, Young HA, Wasserman
K, Ward JM, Kleinman HK, Oppenheim JJ and Murphy WJ: Human
endothelial cells express CCR2 and respond to MCP-1: Direct role of
MCP-1 in angiogenesis and tumor progression. Blood. 96:34–40.
2000.PubMed/NCBI
|
|
28
|
Volp K, Brezniceanu ML, Bösser S, Brabletz
T, Kirchner T, Göttel D, Joos S and Zörnig M: Increased expression
of high mobility group box 1 (HMGB1) is associated with an elevated
level of the antiapoptotic c-IAP2 protein in human colon
carcinomas. Gut. 55:234–242. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Carmeliet P, Dor Y, Herbert JM, Fukumura
D, Brusselmans K, Dewerchin M, Neeman M, Bono F, Abramovitch R,
Maxwell P, et al: Role of HIF-1alpha in hypoxia-mediated apoptosis,
cell proliferation and tumour angiogenesis. Nature. 394:485–490.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Nakagawa T, Li JH, Garcia G, Mu W, Piek E,
Böttinger EP, Chen Y, Zhu HJ, Kang DH, Schreiner GF, et al:
TGF-beta induces proangiogenic and antiangiogenic factors via
parallel but distinct Smad pathways. Kidney Int. 66:605–613. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Grana X and Reddy EP: Cell cycle control
in mammalian cells: Role of cyclins, cyclin dependent kinases
(CDKs), growth suppressor genes and cyclin-dependent kinase
inhibitors (CKIs). Oncogene. 11:211–219. 1995.PubMed/NCBI
|
|
32
|
Hunter T and Pines J: Cyclins and cancer.
II: Cyclin D and CDK inhibitors come of age. Cell. 79:573–582.
1994. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Fimognari C, Nüsse M, Berti F, Iori R,
Cantelli-Forti G and Hrelia P: Cyclin D3 and p53 mediate
sulforaphane-induced cell cycle delay and apoptosis in
non-transformed human T lymphocytes. Cell Mol Life Sci.
59:2004–2012. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Keyomarsi K, Tucker SL, Buchholz TA,
Callister M, Ding Y, Hortobagyi GN, Bedrosian I, Knickerbocker C,
Toyofuku W, Lowe M, et al: Cyclin E and survival in patients with
breast cancer. N Engl J Med. 347:1566–1575. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ohtsubo M, Theodoras AM, Schumacher J,
Roberts JM and Pagano M: Human cyclin E, a nuclear protein
essential for the G1-to-S phase transition. Mol Cell Biol.
15:2612–2624. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Chen L, Wei T, Si X, Wang Q, Li Y, Leng Y,
Deng A, Chen J, Wang G, Zhu S and Kang J: Lysine acetyltransferase
GCN5 potentiates the growth of non-small cell lung cancer via
promotion of E2F1, cyclin D1, and cyclin E1 expression. J Biol
Chem. 288:14510–14521. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Longo VD and Kennedy BK: Sirtuins in aging
and age-related disease. Cell. 126:257–268. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Liu T, Liu PY and Marshall GM: The
critical role of the class III histone deacetylase SIRT1 in cancer.
Cancer Res. 69:1702–1705. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Baylin SB and Herman JG: DNA
hypermethylation in tumorigenesis: Epigenetics joins genetics.
Trends Genet. 16:168–174. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Fosslien E: Molecular pathology of
cyclooxygenase-2 in neoplasia. Ann Clin Lab Sci. 30:3–21.
2000.PubMed/NCBI
|
|
41
|
Daikoku T, Wang D, Tranguch S, Morrow JD,
Orsulic S, DuBois RN and Dey SK: Cyclooxygenase-1 is a potential
target for prevention and treatment of ovarian epithelial cancer.
Cancer Res. 65:3735–3744. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Wu Q, Wang H, Zhao X, Shi Y, Jin M, Wan B,
Xu H, Cheng Y, Ge H and Zhang Y: Identification of
G-protein-coupled receptor 120 as a tumor-promoting receptor that
induces angiogenesis and migration in human colorectal carcinoma.
Oncogene. 32:5541–5550. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Yang DH, Hsu CF, Lin CY, Guo JY, Yu WC and
Chang VH: Kruppel-like factor 10 upregulates the expression of
cyclooxygenase 1 and further modulates angiogenesis in endothelial
cell and platelet aggregation in gene-deficient mice. Int J Biochem
Cell Biol. 45:419–428. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Pittet JF, Koh H, Fang X, Iles K,
Christiaans S, Anjun N, Wagener BM, Park DW, Zmijewski JW, Matthay
MA and Roux J: HMGB1 accelerates alveolar epithelial repair via an
IL-1β- and αvβ6 integrin-dependent activation of TGF-β1. PloS One.
8:e639072013. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Kim HY, Park SY, Lee SW, Lee HR, Lee WS,
Rhim BY, Hong KW and Kim CD: Inhibition of HMGB1-induced
angiogenesis by cilostazol via SIRT1 activation in synovial
fibroblasts from rheumatoid arthritis. PloS One. 9:e1047432014.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Taniura S, Kamitani H, Watanabe T and
Eling TE: Transcriptional regulation of cyclooxygenase-1 by histone
deacetylase inhibitors in normal human astrocyte cells. J Biol
Chem. 277:16823–16830. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Omura N, Griffith M, Vincent A, Li A, Hong
SM, Walter K, Borges M and Goggins M: Cyclooxygenase-deficient
pancreatic cancer cells utilize exogenous sources of
prostaglandins. Mol Cancer Res. 8:821–832. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Kolaczkowska E, Koziol A, Plytycz B,
Arnold B and Opdenakker G: Altered apoptosis of inflammatory
neutrophils in MMP-9-deficient mice is due to lower expression and
activity of caspase-3. Immunol Lett. 126:73–82. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Son DS, Wilson AJ, Parl AK and Khabele D:
The effects of the histone deacetylase inhibitor romidepsin (FK228)
are enhanced by aspirin (ASA) in COX-1 positive ovarian cancer
cells through augmentation of p21. Cancer Biol Ther. 9:928–935.
2010. View Article : Google Scholar : PubMed/NCBI
|
